Together, these studies underscore the complex involvement of APOE in AD pathogenesis, influencing Aβ aggregation and plaque characteristics through multiple cellular pathways, thereby implicating APOE as a potential therapeutic target for modifying disease progression. The gene discussed is APOE; the disease is Alzheimer disease.